January 2025 Newsletter
Safe Biologics
MARCH 10, 2025
Small molecule drugs make up over 90% of prescriptions filled in the U.S. Yet, since the IRAs implementation in 2021, investment in small molecule drug development has dropped by 70% as manufacturers shift resources toward biologics, which have more favorable financial incentives under the law. Read the FTC Report here.
Let's personalize your content